We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Novel ECG Aids Early Diagnosis of Heart Attacks

By HospiMedica staff writers
Posted on 22 Mar 2001
A clinical study has found that an electrocardiac mapping system demonstrated superiority in the early diagnosis of heart attacks in high-risk patients whose symptoms were hard to interpret with a traditional 12-lead ECG. More...
The study was published in the European Heart Journal (2001;22:218-227).

Patients in the study had chest pain symptoms without the classic ST elevation used to identify heart attack in most patients. Instead, these patients exhibited ST depression only, a frequent finding in the 40-50% of heart attack patients without ST elevation. However, ST depression only cannot be relied upon to diagnose a heart attack with traditional ECG technology. Without diagnosis and treatment, these high-risk patients have an early mortality rate of 19%, which increases to 31% after one year

In the study, 54 patients with chest pain and ST depression were evaluated with a standard 12-lead ECG system. They were also evaluated with the Prime ECG system (Meridian Medical Technologies, Inc., Columbia, MD, USA), which employs 80 leads placed around the patient's torso. Standard ECG correctly identified only 38-50% of heart attacks, while Prime ECG detected nearly 90%. Prime ECG includes computer software that rapidly processes heart signals to create full-color, multidimensional diagnostic images designed to be more revealing and more easily interpreted than a traditional ECG pattern.

"The results from our study show the importance of measuring leads outside the conventional precordial area,” noted Dr. Ian Menown and colleagues, who conducted the study at the Royal Victoria Hospital and the University of Ulster in Northern Ireland.



Related Links:
Meridian Medical Technologies

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.